Ironwood Pharmaceuticals

Pear Therapeutics to explore GI indications with its latest pharma partnership
By Dave Muoio | 12:47 pm | October 30, 2019
A new exploratory collaboration with Ironwood Pharmaceuticals comes just a couple weeks after the digital therapeutics startup ended a commercialization relationship with Novartis' Sandoz.